Market Cap 284.95M
Revenue (ttm) 8.33M
Net Income (ttm) -89.30M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,072.03%
Debt to Equity Ratio 0.61
Volume 1,650,000
Avg Vol 2,099,204
Day's Range N/A - N/A
Shares Out 205.00M
Stochastic %K 28%
Beta 0.91
Analysts Strong Sell
Price Target $6.55

Latest News on TSHA

Taysha Gene Therapies Is Showing Promise For Rett Syndrome

Jan 27, 2025, 7:53 PM EST - 2 months ago

Taysha Gene Therapies Is Showing Promise For Rett Syndrome


What's Going On With Taysha Gene Therapies Stock Tuesday?

Jun 18, 2024, 11:42 AM EDT - 10 months ago

What's Going On With Taysha Gene Therapies Stock Tuesday?


Taysha Gene Therapies: TSHA-102's Potential Is A 'Buy'

Nov 3, 2023, 7:41 PM EDT - 1 year ago

Taysha Gene Therapies: TSHA-102's Potential Is A 'Buy'